GSK plc

GLAXF · OTC
Analyze with AI
10/28/2025
9/30/2025
6/30/2025
3/31/2025
Assets
Cash & Equivalents$3,296$3,599$4,464
Short-Term Investments$10$20$21
Receivables$7,937$7,321$7,059
Inventory$6,118$6,072$6,000
Other Curr. Assets$481$661$541
Total Curr. Assets$17,842$17,673$18,085
Property Plant & Equip (Net)$10,132$9,918$9,971
Goodwill$7,117$6,734$6,926
Intangibles$16,865$15,376$16,258
Long-Term Investments$1,083$0$1,011
Tax Assets$6,168$6,581$6,410
Other NC Assets$2,132$2,976$2,044
Total NC Assets$43,497$41,585$42,620
Other Assets$0$0$0
Total Assets$61,339$59,258$60,705
Liabilities
Payables$15,675$14,820$15,149
Short-Term Debt$2,856$0$1,958
Tax Payable$324$581$628
Deferred Revenue$0$0$0
Other Curr. Liab.$2,479$4,977$3,096
Total Curr. Liab.$21,334$20,378$20,831
LT Debt$14,894$0$0
Deferred Rev, NC$0$0$0
Deferred Tax Liab, NC$390$384$404
Other NC Liab.$8,969$24,142$25,816
Total NC Liab.$24,253$24,526$26,220
Other Liabilities$0$0$0
Cap. Leases$0$0$0
Total Liabilities$45,587$44,904$47,051
Equity
Pref Stock$0$0$0
Common Stock$1,349$1,349$1,349
Retained Earnings$10,016$8,797$8,307
AOCI$1,297$0$0
Other Equity$3,486$4,645$4,501
Total Equity$16,148$14,791$14,157
Supplemental Information
Minority Interest-$396-$437-$503
Total Liab. & Tot. Equity$61,339$59,258$60,705
Net Debt$0$14,454-$3,599-$2,506